相关实验视频

Updated: Jun 16, 2025

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Therapeutic Evaluation of Fecal Microbiota Transplantation in an Interleukin 10-Deficient Mouse Model

Published on: April 6, 2022

从到承诺:便微生物群移植支持固体瘤的免疫疗法再敏感化

Laura Chambers¹, Dennis Grencewicz², Daniel Spakowicz³

¹Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, James Hospital and Solove Research Institute, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA.

Cell host & microbe

|August 15, 2024

概括

便微生物群移植 (FMTs) 可以帮助患有难以治疗的癌症的患者. 这项研究表明,FMT可能会使患有食道癌和肝癌的患者重新敏感于癌症免疫疗法.

科学领域:

在瘤学瘤学.
微生物组研究的研究.
免疫治疗是一种免疫疗法.

背景情况:

便微生物群移植 (FMT) 正在成为一种克服黑色素瘤对免疫检查点抑制剂 (ICI) 耐药性的策略.
在其他固体瘤中FMT的疗效在很大程度上仍未被探索.

研究的目的:

调查FMT在改善ICI对黑色素瘤以外的固体瘤的反应方面的潜力.
评估FMT作为食道和肝细胞癌的治疗方法.

主要方法:

金博士及其同事的研究探讨了FMTs在临床前模型或特定固体瘤患者队列中的应用.
分析的重点是瘤反应,免疫细胞透和FMT给药后的微生物组合.

主要成果:

FMT在对治疗耐药的固体瘤,包括食道癌和肝细胞癌,对ICI重新敏感化方面表现出有效性.
通过FMT调节肠道微生物群,影响瘤微环境和全身抗瘤免疫力.

结论:

便微生物群移植是一种有前途的治疗策略,用于扩大免疫检查点抑制剂在各种固体瘤中的效用.
这项研究扩大了FMT在瘤学的应用,为癌症治疗提供了新的途径.

更多相关视频

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Murine Fecal Isolation and Microbiota Transplantation

Murine Fecal Isolation and Microbiota Transplantation

Published on: May 26, 2023

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.